|
|
US20080194698 |
Nmda Receptor Antagonists in the Medical Intervention of Metabolic Disorders
The present invention provides for the use of an NMDA receptor antagonist, preferably memantine or neramexane or a pharmaceutical acceptable salt or a prodrug of said antagonists, in the... |
1000 |